Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-015419 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
49,500
Total Value
$368,141.71
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 200 | $3.79 | $757.96 | 55,486 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 3, 2026 | Sale | 200 | $18.45 | $3,690.00 | 55,286 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 16,300 | $3.79 | $61,773.74 | 71,586 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 4, 2026 | Sale | 16,300 | $18.52 | $301,920.01 | 55,286 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 200 | $0.00 | $0.00 | 69,213 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 4, 2026 | Exercise/Conversion | 16,300 | $0.00 | $0.00 | 52,913 | Direct | โ | View Details |